Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 5/20 | 0.46 |
| ▸ | PDE5A | O76074 | 2/20 | 0.46 |
| ▸ | AURKA | O14965 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | ERN1 | O75460 | 1/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | METAP2 | P50579 | 1/20 | 0.41 |
| ▸ | HTR7 | P34969 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2084338 | 0.84 | NFE2L2 (0.55) | NFE2L2NPC1RAB9AERN1 | |
| SCHEMBL7608689 | 0.82 | ERN1 (0.47) | NFE2L2KDM4ENPC1RAB9ASMN1; SMN2 | |
| SCHEMBL8512088 | 0.82 | S100A4 (0.45) | KDM4ENPC1TP53GAARAB9A | |
| SCHEMBL27255595 | 0.80 | HTT (0.47) | NFE2L2NPC1RAB9ASMN1; SMN2ERN1 | |
| SCHEMBL890949 | 0.80 | S100A4 (0.43) | KDM4ENPC1TP53GAARAB9A | |
| SCHEMBL11617705 | 0.78 | KMT2A (0.46) | HSD17B10KDM4ENPC1TP53RAB9A | |
| SCHEMBL20406217 | 0.77 | POLB (0.50) | NFE2L2PDE5AAURKAHSD17B10KDM4E | |
| SCHEMBL4035576 | 0.77 | ALDH1A1 (0.41) | NPC1GAAPKMRAB9ASMN1; SMN2 | |
| SCHEMBL6065171 | 0.77 | ALDH1A1 (0.53) | PDE5AAURKAHSD17B10KDM4ENPC1 | |
| SCHEMBL14484609 | 0.75 | CLK4 (0.51) | NFE2L2AURKAKDM4ENPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110563641-B | Ortho-halogenated phenyl pyridine ketone compound and preparation method thereof | 三峡大学 | 2023-03-24 | — | — | CN | disclosed |
| EP-1613613-B1 | CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS | GENZYME CORP (US) | 2021-06-02 | — | — | EP | disclosed |
| CN-110563641-A | Ortho-halogenated phenyl pyridine ketone compound and preparation method thereof | 三峡大学 | 2019-12-13 | — | — | CN | disclosed |
| EP-2010550-B1 | POLYMERISATION OF ETHYLENE AND ALPHA-OLEFINS WITH PYRIDINO-IMINOPHENOL COMPLEXES | TOTAL RES & TECHNOLOGY FELUY (BE) | 2013-06-19 | — | — | EP | disclosed |
| US-8399582-B2 | Polymerisation of ethylene and alpha-olefins with pyridino-iminophenol complexes | TOTAL PETROCHEMICALS RESEARCH FELUY (BE) | 2013-03-19 | — | — | US | disclosed |
| US-7863293-B2 | CXCR4 chemokine receptor binding compounds | GENZYME CORPORATION (US) | 2011-01-04 | — | — | US | disclosed |
| US-20100160583-A1 | Polymerisation of Ethylene and Alpha-Olefins with Pyridino-Iminophenol Complexes | TOTAL PETROCHEMICALS RESEARCH FEULY (BE) | 2010-06-24 | — | — | US | disclosed |
| EP-1613613-A4 | CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS | ANORMED INC (CA) | 2009-03-25 | — | — | EP | disclosed |
| US-20080255197-A1 | CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS | ANORMED CORPORATION (CA) | 2008-10-16 | — | — | US | disclosed |
| US-7291631-B2 | CXCR4 chemokine receptor binding compounds | GENZYME CORPORATION (US) | 2007-11-06 | — | — | US | disclosed |
| EP-1613613-A2 | CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS | ANORMED INC. (CA) | 2006-01-11 | — | — | EP | disclosed |
| WO-2004091518-A2 | CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS | ANORMED INC. (CA) | 2004-10-28 | — | — | WO | disclosed |
| US-20040209921-A1 | CXCR4 chemokine receptor binding comounds | ANORMED CORPORATION (CA) | 2004-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040209921-A1 | CXCR4 chemokine receptor binding comounds | CXCR4, CXCR1, CXCR3 | NFE2L2 1677/4885PDE5A 2364/4885AURKA 4523/4885 |
| US-20080255197-A1 | CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS | CXCR4, CXCR1, CXCR3 | NFE2L2 1764/4885PDE5A 1991/4885AURKA 3929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.